Swiss stocks - Factors to watch on May 20
20/05/2020 06:36
ZURICH/BERLIN, May 20 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
CORONAVIRUS
Roche ROG.S said its COVID-19 antibody test is being used
at more than 20 initial lab sites around the United States, with
labs able to perform more than 2 million tests per week by June.
The drug and diagnostics maker said it aims to increase to more
than 200 commercial and hospital lab sites for the tests over
the coming weeks. urn:newsml:reuters.com:*:nFWN2D10RB
Swiss financial supervisor FINMA Said it was extending the
exemption for the calculation of the leverage ratio for all
banks until 1 January 2021, from a previous date of 1 July 2020.
urn:newsml:reuters.com:*:nFWN2D10ZQ
COMPANY STATEMENTS
* Idorsia IDIA.S has raised 330 million Swiss francs
($340.31 million) from a share offering, the drugmaker said on
Wednesday, as it bolsters its coffers for the planned launch of
an insomnia drug and for research and development. urn:newsml:reuters.com:*:nL8N2D20MT
* Compagnie Financiere Richemont CFR.S said it had placed
a 2 billion euro denominated bond. urn:newsml:reuters.com:*:nFWN2D108H
* Meyer Burger MBTN.S : The solar panel equipment
manufacturer said it was told by shareholder Sentis Capital that
a shareholder group with around 12% of voting rights in 2019 had
been terminated. urn:newsml:reuters.com:*:nFWN2D10VD
* SoftwareONE SWON.S said it had acquired Gorillastack to
accelerate its cloud management capabilities for AWS and Azure.
urn:newsml:reuters.com:*:nASN00070C
* Addex Therapeutics ADXN.S said its first-quarter net
loss widened to 4.3 million Sfr. urn:newsml:reuters.com:*:nASN000708
* Orascom Development ODHN.S said its subsidiary ECO-BOS
Development Limited had secured £18 million to kick-start its
1,500 home project in Cornwall, United Kingdom. urn:newsml:reuters.com:*:nFWN2D111Q
* Meier Tobler Group METG.S confirmed key data and
published details on the subscription offer for additional
shares. urn:newsml:reuters.com:*:nFWN2D111P
* Santhera Pharmaceuticals SANN.S completed the enrollment
of a Phase 3 Sideros study with Puldysa. urn:newsml:reuters.com:*:nFWN2D10VJ
* Mikron MIKN.S said it was cutting 47 jobs and reducing
working hours of a further 57 employees as a part of a
restructuring plan to align the company with the market
circumstances. urn:newsml:reuters.com:*:nFWN2D111T
ANALYSTS' VIEWS
JULIUS BAER GRUPPE AG BAER.S : CITIGROUP RAISES PRICE
TARGET TO CHF 41.5 FROM CHF 38, JEFFERIES RAISES PRICE TARGET TO
CHF 47 FROM CHF 43
ECONOMY
No major economic data scheduled.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))